Bronchitis News and Research

RSS

Bronchitis is a condition in which the bronchial tubes, the tubes that carry air to your lungs, become inflamed. (For more information on the bronchial tubes and the airways. People who have bronchitis often have a cough that brings up mucus. Mucus is a slimy substance made by the lining of the bronchial tubes. Bronchitis also may cause wheezing (a whistling or squeaky sound when you breathe), chest pain or discomfort, a low fever, and shortness of breath. There are two main types of bronchitis: acute (short term) and chronic (ongoing).

New flu drug Xofluza approved - FDA emphasizes importance of flu shots

A new drug that works against flu has been developed and has been approved by the Food and Drug Administration (FDA) yesterday (24th October 2018). Until now the only drug available for flu is oseltamivir (Tamiflu) which is to be administered by two pills per day for five days after symptoms appear.

25 Oct 2018

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

New vaccine strategy shows promise to protect chickens against serious respiratory disease

A new vaccine strategy could offer protection to millions of chickens threatened by a serious respiratory disease, research shows.

23 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Study: Urban Inuit communities have more health problems than general Canadian population

Cases of cancer and hypertension are much higher among Inuit living in and around Ottawa than for the general population of Canada's capital city.

10 Oct 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Study shows air pollution may be bad for the fetus

Soot and dust alters thyroid development in fetuses before they are born in smoggy cities, raising concern about health impacts later in life, new USC research shows.

17 Sep 2018

Abnormal levels of metabolites can reliably predict lung disease in 9/11 firefighters

Abnormal levels of more than two dozen metabolites -; chemicals produced in the body as it breaks down fats, proteins and carbohydrates -; can reliably predict which Sept. 11 firefighters developed lung disease and which did not, a new analysis shows.

4 Sep 2018

Oral anticoagulant use after hospital discharge may offer protection from non-fatal blood clots

The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.

27 Aug 2018

Passive smoking exposure among kids greatly increases COPD risk late in life

According to the latest research adults who do not smoke are at a greater risk of dying of serious lung disorders if they grew up around parents who smoked. The study appeared in the latest issue of the journal American Journal of Preventive Medicine.

20 Aug 2018

Study finds role of autoimmunity in development of COPD

Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information stored in Vanderbilt's DNA biobank.

16 Aug 2018

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).

16 Aug 2018

E-cigarettes not so safe but still better than cigarettes

According to latest research vaping using e-cigarettes can hasten the death of lung cells by up to fifty times and cause serious lung diseases later in life. This latest study was published in the journal Thorax.

14 Aug 2018

Breathing ‘a chore’: California wildfires threaten the health of young and old

Debbie Dobrosky noticed a peculiar hue in the sky on Monday — "a very ugly yellow casting" — as she peeked outside. A large cloud of smoke had begun to cover the sun.

8 Aug 2018

No gaps in understanding: Here’s your primer on Medigap coverage

Every year, older adults can opt out of a Medicare Advantage plan and opt in to original Medicare during open enrollment season, which begins on Oct. 15.

26 Jul 2018

Researchers find distinct microbiomes in airway, gastrointestinal systems of children with chronic cough

Different respiratory diseases associated with chronic cough create distinct microbial imbalances in the lower airways of children, according to a study led by researchers at NYU School of Medicine.

26 Jul 2018

FDA requires safety labeling changes for fluoroquinolones to strengthen warnings on adverse reactions

The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.

11 Jul 2018

Tonsil removal as a child could mean chest infections risk as adults

A large study has found that removal of the tonsils as a child can mean that the individual is more susceptible to chest infections as an adult. The study appeared in the latest issue of the journal JAMA Otolaryngology Head and Neck Surgery.

7 Jun 2018

Tonsil and adenoid removal increases long-term risk of respiratory, allergic and infectious diseases

Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, according to researchers who have examined - for the first time - the long-term effects of the operations.